M&A

3 Signs Myriad Genetics' High-Growth Days Are Over
Motley Fool
Thu, 10/12/17 - 09:18 am
Myriad Genetics
M&A
competition
3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff
Motley Fool
Wed, 10/11/17 - 09:55 am
Pfizer
consumer health
M&A
Express Scripts drops $3.6B for healthcare management company
Biopharma Dive
Tue, 10/10/17 - 11:19 pm
Express Scripts
M&A
healthcare management
eviCore
Pfizer to explore potential sale, spinoff of consumer healthcare business
Marketwatch
Tue, 10/10/17 - 09:33 am
Pfizer
consumer health
M&A
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Yahoo/Zacks.com
Mon, 10/9/17 - 11:05 am
Emergent BioSolutions
Sanofi
M&A
smallpox
vaccines
ACAM2000
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz
Endpoints
Mon, 10/9/17 - 09:34 am
Flexion
FDA
osteoarthritis
M&A
Zilretta
Sanofi hires banks to look for buyers of Zentiva
GoinPharma
Sat, 10/7/17 - 11:02 am
Sanofi
Zentiva
M&A
Abbott completes Alere tender offer
Mass Device
Wed, 10/4/17 - 07:02 pm
Abbott Labs
Alere
M&A
diagnostics
devices
From mega-merger to big bang?
Elsevier
Tue, 10/3/17 - 11:38 am
M&A
R&D
Endo, feeling the pricing squeeze, could be the next generics player on the hunt for M&A: Analyst
Fierce Pharma
Tue, 10/3/17 - 11:33 am
Endo International
M&A
Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for?
Fierce Pharma
Mon, 10/2/17 - 10:19 pm
Pfizer
Bristol-Myers Squibb
M&A
Arcturus to go public through merger with Alcobra
BioPharma Dive
Sat, 09/30/17 - 11:53 am
Arcturus
Alcobra
M&A
UPDATE: Abbott plans to close $5B Alere buyout next week
Mass Device
Sat, 09/30/17 - 10:17 am
Abbott
Alere
M&A
devices
Why would Novartis buy a $2.6B radiotherapy maker? Its neuroendocrine franchise, analyst says
Fierce Pharma
Thu, 09/28/17 - 06:28 pm
Novartis
radiotherapy
M&A
Advanced Accelerator Application
neuroendocrine
Buyout buzz: Novartis has been kicking the tires at AAA as FDA reviews Lutathera — report
Endpoints
Thu, 09/28/17 - 11:08 am
Novartis
FDA
Lutathera
M&A
Advanced Accelerator Application
Biotech: The Big Payoff
Seeking Alpha
Sun, 09/24/17 - 10:34 am
biotech
Gilead Sciences
M&A
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Motley Fool
Fri, 09/22/17 - 11:25 am
Gilead Sciences
taxes
Kite Pharma
M&A
Sanofi’s Elias Zerhouni says his R&D group is ready to stand alone — but big M&A and partnerships still loom large
Endpoints
Wed, 09/20/17 - 10:36 am
Sanofi
R&D
M&A
With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica
Endpoints
Tue, 09/19/17 - 08:55 am
CROs
Catalent
M&A
Cook Pharmica
R&D
Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors
Motley Fool
Tue, 09/19/17 - 08:46 am
Gilead Sciences
Kite Pharma
M&A
investors

Pages